Avanos Capital Surpluse from 2010 to 2025

AVNS Stock  USD 16.57  0.06  0.36%   
Avanos Medical Capital Surpluse yearly trend continues to be comparatively stable with very little volatility. Capital Surpluse will likely drop to about 1.7 B in 2025. From the period from 2010 to 2025, Avanos Medical Capital Surpluse quarterly data regression had r-value of  0.83 and coefficient of variation of  6.44. View All Fundamentals
 
Capital Surpluse  
First Reported
2014-12-31
Previous Quarter
1.7 B
Current Value
1.7 B
Quarterly Volatility
46.9 M
 
Yuan Drop
 
Covid
Check Avanos Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Avanos Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 43 M, Interest Expense of 16.1 M or Selling General Administrative of 286.2 M, as well as many indicators such as Price To Sales Ratio of 1.49, Dividend Yield of 0.26 or PTB Ratio of 1.45. Avanos financial statements analysis is a perfect complement when working with Avanos Medical Valuation or Volatility modules.
  
Check out the analysis of Avanos Medical Correlation against competitors.
For more information on how to buy Avanos Stock please use our How to Invest in Avanos Medical guide.

Latest Avanos Medical's Capital Surpluse Growth Pattern

Below is the plot of the Capital Surpluse of Avanos Medical over the last few years. It is Avanos Medical's Capital Surpluse historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Avanos Medical's overall financial position and show how it may be relating to other accounts over time.
Capital Surpluse10 Years Trend
Slightly volatile
   Capital Surpluse   
       Timeline  

Avanos Capital Surpluse Regression Statistics

Arithmetic Mean1,595,536,016
Geometric Mean1,592,623,646
Coefficient Of Variation6.44
Mean Deviation73,957,520
Median1,578,100,000
Standard Deviation102,788,813
Sample Variance10565.5T
Range375.4M
R-Value0.83
Mean Square Error3467.4T
R-Squared0.69
Significance0.000062
Slope17,981,947
Total Sum of Squares158483.1T

Avanos Capital Surpluse History

20251.7 B
20241.9 B
20221.6 B
20211.6 B
20201.6 B
20191.6 B
20181.6 B

About Avanos Medical Financial Statements

Avanos Medical shareholders use historical fundamental indicators, such as Capital Surpluse, to determine how well the company is positioned to perform in the future. Although Avanos Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Avanos Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Avanos Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Capital Surpluse1.9 B1.7 B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Avanos Stock Analysis

When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.